MYGN
Myriad Genetics Inc.
$18.49
Earnings Summary
Revenue | $196.6Mn |
Net Profits | $-31.2Mn |
Net Profit Margins | -15.87% |
Highlights
Myriad Genetics Inc.’s revenue jumped 10.57% since last year same period to $196.6Mn in the Q4 2023. On a quarterly growth basis, Myriad Genetics Inc. has generated 2.45% jump in its revenue since last 3-months.
Myriad Genetics Inc.’s net profit jumped 26.24% since last year same period to $-31.2Mn in the Q4 2023. On a quarterly growth basis, Myriad Genetics Inc. has generated 49.1% jump in its net profits since last 3-months.
Myriad Genetics Inc.’s net profit margin jumped 33.29% since last year same period to -15.87% in the Q4 2023. On a quarterly growth basis, Myriad Genetics Inc. has generated 50.32% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Myriad Genetics Inc. post its latest quarter earnings
EPS Estimate Current Quarter | -0.1 |
EPS Estimate Current Year | -0.1 |
Highlights
Myriad Genetics Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.1 - a -1100% fall from last quarter’s estimates.
Myriad Genetics Inc.’s earning per share (EPS) estimates for the current year stand at -0.1.
Key Ratios
Key ratios of the Myriad Genetics Inc. post its Q4 2023 earnings
Earning Per Share (EPS) | 0.04 |
Highlights
Myriad Genetics Inc.’s earning per share (EPS) jumped 133.33% since last year same period to 0.04 in the Q4 2023. This indicates that the Myriad Genetics Inc. has generated 133.33% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-05-04 | -0.19 | -0.21 | -10.53% |
2023-11-07 | -0.08 | -0.03 | 62.5% |
2023-08-04 | -0.08 | -0.08 | 0% |
₹0 US Stocks a/c Opening Fee